Or a raise at a premium with heavy interest from institutional investors. I will be sorely disappointed if the raise is conducted at market rate or below.
Given the relatively limited liquidity of the stock, it’s not overly fair on holders that institutions be allowed substantial access at current prices when they otherwise wouldn’t be able to accumulate at these levels.
I’m not a man of faith, but I am praying that the board values themselves and their holders. 3c or above for the raise will ease my tension.
- Forums
- ASX - By Stock
- Ann: Trading Halt
ECS
ecs botanics holdings ltd
Add to My Watchlist
0.00%
!
1.0¢

Or a raise at a premium with heavy interest from institutional...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.96M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $2.556K | 255.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 3905455 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 3524645 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 3905455 | 0.009 |
24 | 12886241 | 0.008 |
13 | 9804664 | 0.007 |
8 | 2233450 | 0.006 |
3 | 3400000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 3524645 | 8 |
0.011 | 4467487 | 7 |
0.012 | 2168089 | 4 |
0.013 | 80000 | 1 |
0.014 | 36071 | 1 |
Last trade - 10.52am 04/07/2025 (20 minute delay) ? |
Featured News
ECS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online